Skip to main content
Clinical Trials/ISRCTN17662153
ISRCTN17662153
Completed
Phase 1

A phase I, double-blind, randomized study to evaluate the safety and immunogenicity of a new Meningococcal A Conjugate vaccine versus a Meningococcal Polysaccharide A+C reference vaccine and a Tetanus Toxoid control vaccine, given as single intramuscular injections in healthy adults from 18 to 35 years of age (India)

Serum Institute of India Limited (SIIL) (Secondary Sponsor - Program for Appropriate Technology in Health [PATH], USA)0 sites72 target enrollmentJuly 22, 2005

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Meningococcal disease
Sponsor
Serum Institute of India Limited (SIIL) (Secondary Sponsor - Program for Appropriate Technology in Health [PATH], USA)
Enrollment
72
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

Registry
who.int
Start Date
July 22, 2005
End Date
July 31, 2006
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Serum Institute of India Limited (SIIL) (Secondary Sponsor - Program for Appropriate Technology in Health [PATH], USA)

Eligibility Criteria

Inclusion Criteria

  • Healthy adults between 18 and 35 years of age

Exclusion Criteria

  • Any condition that may affect the health of the subject or the interpretation of the results; pregnancy or lactation

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
A phase II, double-blind, randomised, controlled, dose ranging study to evaluate the safety, immunogenicity, dose response and schedule response of a meningococcal A conjugate vaccine administered concomitantly with local expanded program on immunisation (EPI) vaccines in healthy infantsBacterial meningitisNervous System Diseases
ISRCTN82484612Serum Institute of India Limited1,200
Completed
Not Applicable
Clinically important venous thromboembolism following lower extremity fractures: epidemiology and preventioIsolated below-knee fractures (tibia and/or fibula) requiring surgical repairInjury, Occupational Diseases, PoisoningFractures
ISRCTN23254458niversity of Toronto (Canada)700
Completed
Phase 2
A phase II/III, observer-blind, randomised, active controlled study to compare the safety and immunogenicity of a meningococcal A conjugate vaccine (PsA-TT) with meningococcal ACWY polysaccharide vaccine administered in healthy children 2 to 10 years of age
ISRCTN46335400Serum Institute of India Limited (SIIL)340
Completed
Phase 4
A multicentre, double-blind, randomised, phase IV clinical trial comparing the safety, tolerability and efficacy of levetiracetam versus lamotrigine and carbamazepine in the oral antiepileptic therapy of newly diagnosed elderly patients with focal epilepsy
ISRCTN94839639niversity of Mainz Medical Faculty (Germany)360
Completed
Not Applicable
A pilot study on the effect of niacin on pulmonary arterial pressurePulmonary hypertensionCirculatory SystemPrimary pulmonary hypertension
ISRCTN12353191Georgetown University Institutional Review Board49